Author:
Panzade Prabhakar, ,Shendarkar Giridhar
Abstract
The objective of the present investigation was to enhance the solubility and dissolution rate of BCS class II drug nevirapine through scalable and commercially feasible solid dispersion approach by using Soluplus® (BASF) as hydrophilic carrier. The solid dispersion produced by melting method (1:5 weight ratio) exhibited highest solubility ~ 15 folds greater than pure drug. The changes in DSC, PXRD, and SEM validated the formation of solid dispersion and transformation of drug from crystalline to amorphous form. Besides, selected solid dispersion had better flow properties and higher dissolution rate than nevirapine. Furthermore, the two dissolution profiles were different (f2 value 33). Hence, preparation of nevirapine-soluplus® solid dispersion by melting method could be an appropriate pharmaco technical strategy to enhance the solubility and dissolution rate of nevirapine and probably other BCS class II drugs.
Publisher
Indian Drug Manufacturers' Association (IDMA)
Subject
Drug Discovery,Pharmaceutical Science,Pharmacology
Reference8 articles.
1. 1. Panzade P.S., Priyanka S. and Pavan R.: Nevirapine Pharmaceutical Cocrystal: Design, Development and Formulation. Drug Deliv Lett. 2019, 9(3), 240-247.
2. 2. Costa R. N., Reviglio A. L., Siedler S., Cardoso S. G., Garro Linck Y., Monti G.A. et al.: New multicomponent forms of the antiretroviral Nevirapine with improved dissolution performance. Cryst Growth Des. 2019, 20(2), 688-698.
3. 3. Raju A., Reddy A. J., Satheesh J. and Jithan A.V.: Preparation and characterisation of nevirapine oral nanosuspensions. Indian J Pharm Sci. 2014, 76(1), 62-71.
4. 4. Teixeira C. C., Mendonça L. M., Bergamaschi M. M., Queiroz R. H., Souza G. E., Antunes L. M. et al.: Microparticles containing curcumin solid dispersion: stability, bioavailability and anti-inflammatory activity. AAPS PharmSciTech. 2016, 17(2), 252-261.
5. 5. Huang Y. and Dai W.G.: Fundamental aspects of solid dispersion technology for poorly soluble drugs. Acta Pharm Sin B. 2014, 4(1), 18-25.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献